Novo Nordisk. March 19, 2014. Positive results from first phase 3 trial with N8-GP, a long-acting factor VIII for treatment of haemophilia A. Available at: http://www.novonordisk.com/include/asp/exe_news_attachment.asp?sAttachmentGUID=31C49463-5E29-4262-9E4D-F8C47E96A57B Accessed May 16, 2014.
Download Bibliographical Data
We do not assume any responsibility for the contents of the web pages of other providers.